<DOC>
	<DOC>NCT01534273</DOC>
	<brief_summary>The purpose of this phase I study in healthy participants will be to evaluate the safety and tolerability of LY2886721 single and multiple doses, how the body handles the drug and the drug's effect on the body.</brief_summary>
	<brief_title>A Study of LY2886721 in Healthy Participants</brief_title>
	<detailed_description />
	<criteria>Healthy men and nonchildbearing potential women Body mass index between 18.032.0 kg/m^2 Are reliable and willing to make yourself available for the duration of the study and are willing to follow study procedures and research unit policies Taking overthecounter or prescription medication with the exception of vitamins or minerals Smoke more than 10 cigarettes per day Drink more than 5 cups of caffeine containing beverages (e.g., coffee, tea) per day</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Mild Cognitive Impairment</keyword>
</DOC>